AISLING CAPITAL III LP

10% owner at Zeltiq Aesthetics Inc · on record since Oct 25, 2011
10% owner at Durata Therapeutics, Inc. · on record since Jul 25, 2012
10% owner at CELLULAR TECHNICAL SERVICES CO INC · on record since Sep 5, 2013
10% owner at Versartis, Inc. · on record since Mar 27, 2014
Director at AGILE THERAPEUTICS INC · on record since May 28, 2014
10% owner at AGILE THERAPEUTICS INC · on record since May 28, 2014
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at T2 Biosystems, Inc. · on record since Aug 14, 2014
Former 10% Owner at CELLULAR TECHNICAL SERVICES CO INC · on record since Feb 5, 2016
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016

Insider trading activity of AISLING CAPITAL III LP

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
Loxo Oncology, Inc.	Dec 15, 2015	Buy	200	27.50 USD	$5.5K	SEC
Loxo Oncology, Inc.	Aug 6, 2014	Buy	413,077	13.00 USD	$5.4M	SEC
Loxo Oncology, Inc.	Aug 6, 2014	Other	2,850,709	0.00 USD	$0	SEC
Loxo Oncology, Inc.	Aug 6, 2014	OtherD	-2,343,749	0.00 USD	$0	SEC
Loxo Oncology, Inc.	Aug 6, 2014	OtherD	-506,960	0.00 USD	$0	SEC
Durata Therapeutics, Inc.	May 22, 2014	Other	-3,528	0.00 USD	$0	SEC
Durata Therapeutics, Inc.	May 22, 2014	Other	-745,730	0.00 USD	$0	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Loxo Oncology, Inc.	Dec 15, 2015	Buy	200	27.50 USD	$5.5K	SEC
Loxo Oncology, Inc.	Aug 6, 2014	Buy	413,077	13.00 USD	$5.4M	SEC
Loxo Oncology, Inc.	Aug 6, 2014	Other	2,850,709	0.00 USD	$0	SEC
Loxo Oncology, Inc.	Aug 6, 2014	OtherD	-2,343,749	0.00 USD	$0	SEC
Loxo Oncology, Inc.	Aug 6, 2014	OtherD	-506,960	0.00 USD	$0	SEC
Durata Therapeutics, Inc.	May 22, 2014	Other	-3,528	0.00 USD	$0	SEC
Durata Therapeutics, Inc.	May 22, 2014	Other	-745,730	0.00 USD	$0	SEC